26 March 2018

TIKOMED CEO IS PANELIST AT EUROPE CEO IN AMSTERDAM

TikoMeds CEO represented TikoMed at the Europe CEO meeting prior to the BIO Europe spring event.
The panel discussed the topic of how to build a biotech company in Europe. Several parts of the structural process was touched upon but in essence the panelists concurred that people, in every aspect is the essence. The chain from founders, owners, board, management and staff needs to be crisp, diligent and professional. In turn that will provide for efficient positioning, funding, strategy and execution of plans.

DATE
TBA

TIME
TBA

VENUE
TBA

OTHER NEWS

4 March 2019
TFS International AB (TFS) appointed CRO representative for TIKOMED’s phase 2 study in clinical islet transplantation
Viken – 4th March 2019 – TIKOMED, a Swedish privately held biopharmaceutical company today announced…
Read More
8 February 2019
TIKOMED successfully closed fundraising of 8 Million Euros
Viken – 8th February 2019 – TIKOMED, a Swedish privately-held biopharmaceutical company today announced its…
Read More
6 February 2019
Shadow Lake Group appointed Strategic Advisor and Business Development representative for the licensing process of IBsolvMIR® in Canada
Viken – 6th February 2019 – TIKOMED, a Swedish privately held biopharmaceutical company today announced…
Read More
SEE MORE